Atossa Therapeutics, Inc.
USD2.40
-0.09 (-3.61%)
CEO
Steven C. Quay
IPO Date
2012-11-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.46
Prev. Close
$2.49
Day Low
$2.40
Day High
$2.56
52W Low
$1.70
52W High
$19.35
Market Cap
$0.02B
Volume
0.10M
| 10,000 |
| $0.00 |
| 14 May 2026 | Remmel H. Lawrence | director | A-Award | Acquired | 10,000 | $0.00 |
| 14 May 2026 | Finn Jonathan | director | A-Award | Acquired | 10,000 | $0.00 |
| 14 May 2026 | Galli Stephen J | director | A-Award | Acquired | 10,000 | $0.00 |
| 14 May 2026 | Cigler Tessa | director | A-Award | Acquired | 10,000 | $0.00 |
| 31 Mar 2026 | QUAY STEVEN C | director, officer: President & CEO | A-Award | Acquired | 65,000 | $0.00 |
| 30 Mar 2026 | Daniel Mark James | Chief Financial Officer | A-Award | Acquired | 63,000 | $0.00 |
| 30 Jan 2026 | QUAY STEVEN C | director, officer: President & CEO | A-Award | Acquired | 331,674 | $0.00 |
| 22 Jan 2026 | QUAY STEVEN C | director, officer: President & CEO | A-Award | Acquired | 325,203 | $0.00 |